{"id":"W2161313492","doi":"10.1007/s40261-014-0266-2","title":"Comparative Changes of Lipid Levels in Treatment-Naive, HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks","year":2015,"lang":"en","type":"review","venue":"Clinical Drug Investigation","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"ViiV Healthcare; GlaxoSmithKline","keywords":"Darunavir; Dolutegravir; Raltegravir; Efavirenz; Medicine; Ritonavir; Integrase inhibitor; Pharmacology; Pharmacotherapy; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy; Internal medicine; Viral load","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000686128,0.001020141,0.004645805,0.000678651,0.000146311,0.00003167001,0.0001953902,0.0009363844,0.00003940495],"category_scores_gemma":[0.0002117028,0.0007103451,0.000347024,0.001396211,0.0009487779,0.0001369548,0.00005316069,0.001049072,0.0001071352],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007446793,"about_ca_system_score_gemma":0.001926049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001277282,"about_ca_topic_score_gemma":0.0005595307,"domain_scores_codex":[0.9940063,0.00137805,0.002269332,0.001289648,0.00050372,0.0005528939],"domain_scores_gemma":[0.9945658,0.001266482,0.001744477,0.001003216,0.000529293,0.0008907688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004359283,0.008747147,0.1646861,0.02031817,0.003388024,0.0002718444,0.003576536,0.00001745814,0.00001617052,0.0003881741,0.008682732,0.7855484],"study_design_scores_gemma":[0.0569577,0.01336473,0.1611243,0.1341148,0.01174984,0.0001419327,0.0002677881,0.002225527,0.000114397,0.0002155598,0.6172447,0.002478682],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2863205,0.698056,0.00001240072,0.001139716,0.0002560271,0.01077596,0.002191823,0.0003042349,0.0009433486],"genre_scores_gemma":[0.03422627,0.9395304,0.002533888,0.0003810923,0.0003942994,0.001687657,0.01871694,0.0002652997,0.002264092],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7830697,"threshold_uncertainty_score":0.9995348,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1577327112019011,"score_gpt":0.4296276152708972,"score_spread":0.2718949040689961,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}